CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Lanreotide acetate

Last Updated: February 20, 2007
Result type: Reports
Project Number: S0091
Product Line: Common Drug Review

Generic Name: Lanreotide acetate

Brand Name: Somatuline Autogel

Manufacturer: Ipsen Limited

Indications: Acromegaly

Submission Type: New

Project Status: Complete

Date Recommendation Issued: July 19, 2007

Recommendation Type: List in a similar manner to other drugs in class